Gilead posts profit, says HIV prevention drug on track for mid-June

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. COST
2. AKAM
3. SPY
4. ZS
5. ULS
6. META
7. CRL
8. PRME
9. CNP
10. BNED

Go back to Gilead posts profit, says HIV prevention drug on track for mid-June
Gilead Sciences (NASDAQ: GILD) Delayed: 149.69 --0 (-0%)
Previous Close $149.69    52 Week High $108.63 
Open $149.69    52 Week Low $71.39 
Day High $149.69    P/E 82.70 
Day Low $149.69    EPS $1.81 
Volume 2,654